Ragu Varman Durairaj | Innovative Research Award | biological networks

Innovative Research Award

   Ragu Varman Durairaj
Affiliation Sri Balaji Vidyapeeth (Deemed to be University)
Country India
Scholar ID 99QTjiYAAAAJ&hl
Documents 41
Citations 528
h-index 13
Subject Area biological networks
Event International Research Awards on Network Science & Graph Analytics
ORCID 0000-0002-9409-9456

Ragu Varman Durairaj
Sri Balaji Vidyapeeth (Deemed to be University)

Ragu Varman Durairaj is a researcher affiliated with Sri Balaji Vidyapeeth (Deemed to be University), India, whose reported scholarly profile includes 41 documents, 528 citations, and an h-index of 13. His stated subject area is Molecular research, positioning his work within a field that encompasses molecular structure, interactions, biological processes, computational approaches, and related interdisciplinary investigations.

Abstract

This academic recognition profile presents Ragu Varman Durairaj in connection with the Innovative Research Award. The researcher is affiliated with Sri Balaji Vidyapeeth (Deemed to be University), India, and is identified with the Molecular subject area. The reported scholarly record comprises 41 documents, 528 citations, and an h-index of 13. These indicators provide a quantitative context for examining research productivity and scholarly visibility, while the award framework places additional emphasis on originality, relevance, and contribution to research development. Bibliometric indicators are commonly used as complementary measures rather than as standalone assessments of research quality.[1]

Keywords

  • Innovative Research Award
  • Molecular Research
  • Research Innovation
  • Scientific Publications
  • Research Impact
  • Bibliometric Indicators
  • Academic Recognition
  • Network Science

Introduction

Molecular research occupies an interdisciplinary position connecting chemistry, biology, medicine, computational science, and related fields. Modern molecular investigations frequently integrate experimental and computational methods to examine structures, interactions, mechanisms, and biological or chemical functions. Computational molecular approaches, including molecular simulation and molecular dynamics, can provide insight into atomistic behavior and molecular interactions that complement experimental research.[2]

Within this broader research environment, academic recognition can consider both measurable scholarly output and the substantive contribution of a research program. The Innovative Research Award therefore provides a framework for acknowledging research that demonstrates originality and meaningful advancement while remaining grounded in established scholarly standards.

Research Profile

Ragu Varman Durairaj is associated with Sri Balaji Vidyapeeth (Deemed to be University) in India. The supplied research profile identifies Molecular as the principal subject area and reports 41 documents, 528 citations, and an h-index of 13. These figures indicate a sustained body of documented scholarly work and a measurable citation record. Citation counts and h-index values, however, should be interpreted in relation to disciplinary norms, publication age, authorship patterns, and the specific research questions addressed.[1]

The reported Google Scholar identifier is 99QTjiYAAAAJ&hl. An ORCID identifier and Scopus Author ID were not supplied in the source information for this profile and are therefore not inferred.

Research Contributions

The research profile is situated within the Molecular subject area, where contributions may involve the study of molecular structures, interactions, mechanisms, computational modeling, or applications in biological and chemical systems. Molecular research commonly benefits from interdisciplinary methodologies because molecular phenomena can be examined through complementary theoretical, computational, and experimental perspectives.[2]

For award assessment, the relevant contribution is best evaluated through the originality of the research questions, methodological rigor, reproducibility, publication quality, relevance to the field, and demonstrated influence on subsequent research. The supplied bibliometric record provides supporting quantitative context but does not, by itself, establish the scientific quality of individual publications.

Publications

The supplied profile reports 41 scholarly documents. Individual publication titles, journals, publication years, authorship information, and DOI identifiers were not provided in the source data. Consequently, this article does not attribute specific publications to the researcher without verifiable bibliographic information. A complete publication assessment should examine peer-reviewed articles, conference contributions, reviews, datasets, and other scholarly outputs where applicable.

For molecular research, DOI-linked literature can support transparent verification of publication records and facilitate reliable access to scholarly sources. Standard molecular simulation literature, for example, emphasizes the importance of validated computational methodologies and careful interpretation of molecular behavior.[2]

Research Impact

The reported 528 citations and h-index of 13 provide indicators of scholarly visibility within indexed citation environments. Such metrics can help contextualize the reach of a research portfolio, but responsible research assessment recommends using quantitative indicators alongside qualitative evidence concerning research quality, significance, openness, collaboration, and broader contributions.[1]

Potential impact in molecular research can extend beyond citation counts through methodological adoption, interdisciplinary collaboration, educational use, translational relevance, and contribution to the understanding of molecular systems. A rigorous assessment should therefore consider evidence appropriate to the researcher’s specific area and career stage.

Award Suitability

Based on the supplied profile, Ragu Varman Durairaj is a relevant candidate for consideration for the Innovative Research Award because the record identifies a defined Molecular research area together with 41 documents, 528 citations, and an h-index of 13. These indicators establish a documented scholarly profile that can support further evaluation of research originality and influence.

  • A documented body of 41 research documents.
  • A reported citation count of 528.
  • A reported h-index of 13.
  • A defined research focus within the Molecular subject area.
  • Institutional affiliation with Sri Balaji Vidyapeeth (Deemed to be University).

Final award suitability should additionally be determined through independent review of the nominee’s publications, originality, methodological quality, contribution to the field, and supporting evidence submitted for the award process. Bibliometric information should be treated as supporting evidence rather than the sole basis for recognition.[1]

Conclusion

Ragu Varman Durairaj’s supplied academic profile reflects research activity in the Molecular subject area and a measurable scholarly record of 41 documents, 528 citations, and an h-index of 13. These indicators provide a useful foundation for academic recognition.

The Innovative Research Award can recognize such research when supported by evidence of originality, methodological rigor, scholarly contribution, and meaningful influence. A complete assessment should combine bibliometric indicators with qualitative examination of the underlying research outputs.

References

  1. Hicks, D., Wouters, P., Waltman, L., de Rijcke, S., & Rafols, I. (2015). Bibliometrics: The Leiden Manifesto for research metrics. Nature, 520, 429–431.https://doi.org/10.1038/520429a
  2. Hollingsworth, S. A., & Dror, R. O. (2018). Molecular dynamics simulation for all. Neuron, 99(6), 1129–1143.https://doi.org/10.1016/j.neuron.2018.08.011
  3. International Research Awards on Network Science & Graph Analytics. (n.d.).
    Award Website.https://networkscience-conferences.researchw.com/

Anastasia Bougea | Biological Networks | Innovative Research Award

Innovative Research Award

Anastasia Bougea
National and Kapodistrian University of Athens

Anastasia Bougea
Affiliation National and Kapodistrian University of Athens
Country Greece
Scopus ID 55629725400
Documents 136
Citations 2352
h-index 27
Subject Area Biological Networks
Event International Research Awards on Network Science & Graph Analytics
ORCID 0000-0003-3006-8711

Anastasia Bougea is a Greek researcher affiliated with the National and Kapodistrian University of Athens whose scholarly work spans neurology, neurodegenerative diseases, clinical neuroscience, digital health, and data-driven approaches to understanding complex biological systems. Her publication record demonstrates sustained contributions to Parkinson’s disease, dementia-related disorders, neuropsychological assessment, and emerging machine-learning methodologies in healthcare research.[1] Through interdisciplinary investigations integrating clinical evidence, neurological biomarkers, and computational analysis, her research aligns with contemporary developments in biological network science and translational medicine.[2]

Abstract

This article summarizes the academic profile of Anastasia Bougea and evaluates her suitability for recognition through the Innovative Research Award. Her body of work reflects a multidisciplinary approach linking neurological disorders, clinical diagnostics, machine learning, mobile health technologies, and molecular mechanisms of neurodegeneration. The scope and continuity of her contributions indicate an active engagement with contemporary biomedical challenges and network-oriented approaches to disease understanding.[3]

Keywords

Biological Networks, Neurodegenerative Diseases, Parkinson’s Disease, Machine Learning, Clinical Neuroscience, Mobile Health, Dementia, Alpha-Synuclein, Biomarkers, Graph Analytics.

Introduction

Research into neurodegenerative diseases increasingly relies on interconnected biological data, computational modeling, and predictive analytics. Anastasia Bougea’s scholarly activities contribute to this evolving landscape through studies addressing disease mechanisms, clinical assessment tools, and technology-assisted healthcare solutions. Her work demonstrates the integration of biomedical knowledge with analytical methods relevant to modern network science applications.[4]

Research Profile

With 136 indexed publications, 2,352 citations, and an h-index of 27, Bougea has established a substantial academic presence. Her research portfolio encompasses Parkinson’s disease, dementia with Lewy bodies, frontotemporal dementia, non-coding RNA therapeutics, and digital health technologies. Her publication activity reflects sustained engagement with peer-reviewed international journals and collaborative research initiatives.[1]

Research Contributions

  • Applied machine learning techniques for predicting multiple system atrophy and progressive supranuclear palsy.
  • Investigated therapeutic opportunities involving non-coding RNAs in neurodegenerative diseases.
  • Reviewed molecular pathways associated with alpha-synuclein and GBA1-related neurological disorders.
  • Explored mobile health technologies supporting Parkinson’s disease management.

Publications

  • Machine learning-based prediction of multiple system atrophy and progressive supranuclear palsy using clinical and neuropsychological scores (2026).
  • Targeting Non-Coding RNAs as a Potential Therapeutic and Delivery Strategy Against Neurodegenerative Diseases (2026).
  • Role of Alpha-Synuclein in Frontotemporal Dementia: Narrative Review (2026).
  • Underlying Mechanisms of GBA1 in Parkinson’s Disease and Dementia with Lewy Bodies (2025).
  • Mobile Health Technologies for the Management of Parkinson’s Disease (2025).

Research Impact

The impact of Bougea’s research is reflected through citation activity, interdisciplinary relevance, and practical implications for neurological healthcare. Her studies support improved understanding of disease progression, digital monitoring technologies, and predictive clinical tools. These contributions help bridge translational research with patient-centered applications and data-driven decision-making frameworks.[5]

Award Suitability

Anastasia Bougea demonstrates characteristics commonly associated with innovative research recognition, including interdisciplinary scholarship, measurable scientific impact, and continued publication productivity. Her integration of machine learning, molecular neuroscience, and mobile health technologies contributes to emerging approaches within biological networks and graph-informed biomedical analysis. These achievements provide a strong basis for consideration within the International Research Awards on Network Science & Graph Analytics.[6]

Conclusion

Bougea’s academic record reflects sustained contributions to neuroscience and neurodegenerative disease research. Her work combines clinical relevance with analytical innovation, supporting advancements in predictive medicine and network-based biomedical understanding. The breadth of her scholarly output and demonstrated impact support recognition within an international research award framework.

References

  1. Elsevier. (n.d.). Scopus author details: Anastasia Bougea, Author ID 55629725400. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=55629725400
  2. Bougea, A. (2026). Machine learning-based prediction of multiple system atrophy and progressive supranuclear palsy using clinical and neuropsychological scores.
    DOI: https://doi.org/10.1016/j.bnd.2026.02.002
  3. Bougea, A. (2026). Targeting Non-Coding RNAs as a Potential Therapeutic and Delivery Strategy Against Neurodegenerative Diseases.
    DOI: https://doi.org/10.3390/ijms27073260
  4. Bougea, A. (2026). Role of Alpha-Synuclein in Frontotemporal Dementia: Narrative Review.
    DOI: https://doi.org/10.3390/cells15050470
  5. Bougea, A. (2025). Underlying Mechanisms of GBA1 in Parkinson’s Disease and Dementia with Lewy Bodies.
    DOI: https://doi.org/10.3390/genes16121496
  6. Bougea, A. (2025). Mobile Health Technologies for the Management of Parkinson’s Disease.
    DOI: https://doi.org/10.1080/14737175.2025.2580468

Alexander Kruglov | Biological Networks | Best Researcher Award

Assist. Prof. Dr. Alexander Kruglov | Biological Networks | Best Researcher Award

Head of Clinical Microbiology at Moscow Department of Health MMCC”Kommunarka”, Russia📖

Dr. Alexander N. Kruglov is a distinguished microbiologist with over 40 years of experience in clinical microbiology and infectious diseases. He has dedicated his career to advancing microbiological research, laboratory management, and the study of antimicrobial resistance. Dr. Kruglov has held key leadership roles in various prestigious medical institutions, contributing significantly to the understanding and management of infectious diseases. His expertise spans microbiological diagnostics, antimicrobial resistance surveillance, and clinical bacteriology.

Profile

Orcid Profile

Education Background🎓

Dr. Kruglov obtained his Doctor of General Medicine degree from Saratov State Medical Institute in 1981. He pursued postgraduate training in Microbiology and earned his Ph.D. from the All-Russian Research Institute of Applied Microbiology in 1984. Additionally, he has undergone specialized training in medical microbiology, bacteriology, and clinical trial methodologies at esteemed institutions such as the I.M. Sechenov Moscow Medical Academy and N.I. Pirogov Russian Scientific Research Medical University.

Professional Experience🌱

Currently serving as the Head of the Laboratory of Clinical Microbiology at the Moscow City Multidisciplinary Clinical Center “Kommunarka” since 2020, Dr. Kruglov has been instrumental in managing microbiological diagnostics in a high-complexity healthcare setting. Prior to this, he led clinical microbiology laboratories at City Hospital No. 24 and the National Agency of Clinical Pharmacology and Pharmacy. His career also includes extensive research roles at the All-Russian Research Institute of Applied Microbiology and the I.M. Sechenov Moscow Medical Academy. With over three decades of expertise in clinical microbiology, he has been at the forefront of infection control and antimicrobial resistance research.

Research Interests🔬

Dr. Kruglov’s research primarily focuses on antimicrobial resistance mechanisms, clinical microbiology, and infectious disease epidemiology. He has contributed significantly to understanding carbapenem-resistant microorganisms, Candida auris population structures, and the impact of antifungal susceptibility on clinical outcomes. His work also includes studying risk factors associated with microbial colonization in intensive care units and exploring novel antimicrobial strategies against multidrug-resistant pathogens.

Author Metrics

Dr. Kruglov has co-authored several high-impact publications in peer-reviewed journals, covering topics such as carbapenem resistance, fungal infections, and antibiotic susceptibility. His recent works include studies published in the Journal of Epidemiology and Vaccinal Prevention, Journal of Fungi, and Russian Journal of Anesthesiology and Reanimatology. His research contributions have advanced clinical microbiology practices, providing valuable insights into microbial epidemiology and resistance patterns.

Awards & Honors

Dr. Kruglov has received multiple recognitions for his contributions to medical microbiology and infectious disease research. His work has been instrumental in shaping laboratory practices and infection control policies in healthcare settings. He continues to be a key figure in microbiological research, mentoring young scientists and leading critical investigations in clinical bacteriology.

Publications Top Notes 📄

1. Prevalence and Risk Factors for Colonization with Carbapenem-Resistant Microorganisms in Patients Admitted to a Multidisciplinary Hospital

  • Journal: Epidemiology and Vaccinal Prevention
  • Publication Date: January 14, 2025
  • DOI: 10.31631/2073-3046-2024-23-6-83-103
  • Contributors: O. G. Ni, B. Z. Belotserkovskiy, A. N. Kruglov, M. I. Matyash, A. O. Bykov, S. V. Yakovlev, E. M. Shifman, D. N. Protsenko
  • Source: Crossref

2. Population Structure Based on Microsatellite Length Polymorphism, Antifungal Susceptibility Profile, and Enzymatic Activity of Candida auris Clinical Isolates in Russia

  • Journal: Journal of Fungi
  • Publication Date: January 4, 2025
  • DOI: 10.3390/jof11010035
  • Contributors: Ellina Oganesyan, Victoria Klimenteva, Irina Vybornova, Valentina Venchakova, Ekaterina Parshikova, Sergey Kovyrshin, Olga Orlova, Alexander Kruglov, Svetlana Gordeeva, Natalya Vasilyeva
  • Source: Crossref

3. Risk Factors of Colonization and Diversity of Clinically Significant Carbapenemases in Gut Microbiota of ICU Patients: A Single-Center Prospective Observational Study

  • Journal: Russian Journal of Anesthesiology and Reanimatology
  • Publication Date: 2024
  • DOI: 10.17116/anaesthesiology202405141
  • Contributors: A.O. Bykov, E.M. Shifman, D.N. Protsenko, S.V. Yakovlev, B.Z. Belotserkovskiy, O.G. Ni, A.N. Kruglov, A.A. Bryleva, M.I. Matyash, E.S. Larin
  • Source: Crossref

4. Comparative Activity of Lipoglycopeptide Antibiotics Against Gram-Positive Bacteria

  • Journal: Antibiotics and Chemotherapy
  • Publication Date: December 28, 2022
  • DOI: 10.37489/0235-2990-2022-67-9-10-18-24
  • Contributors: V. V. Gostev, O. S. Sulian, O. S. Kalinogorskaya, L. N. Popenko, A. N. Kruglov, S. A. Gordeeva, E. V. Nesterova, D. P. Gladin, N. N. Trophimova, P. S. Chulkova
  • Source: Crossref

Conclusion

Dr. Alexander Kruglov is an excellent candidate for the Best Researcher Award in Biological Networks due to his outstanding contributions to clinical microbiology, antimicrobial resistance research, and infectious disease epidemiology. His extensive leadership, impactful publications, and dedication to microbiological advancements make him a top contender.

To further strengthen his impact, increased international collaboration, expansion into emerging fields, and greater public outreach could enhance his already distinguished career. Nonetheless, his research achievements and scientific leadership fully justify his nomination for this prestigious award.